MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou, 350108, China.
Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD, 20892, USA.
Adv Mater. 2019 Sep;31(37):e1903443. doi: 10.1002/adma.201903443. Epub 2019 Aug 5.
The targeted and sustained drug release from stimuli-responsive nanodelivery systems is limited by the irreversible and uncontrolled disruption of the currently used nanostructures. Bionic nanocapsules are designed by cross-linking polythymine and photoisomerized polyazobenzene (PETAzo) with adenine-modified ZnS (ZnS-A) nanoparticles (NPs) via nucleobase pairing. The ZnS-A NPs convert X-rays into UV radiation that isomerizes the azobenzene groups, which allows controlled diffusion of the active payloads across the bilayer membranes. In addition, the nucleobase pairing interactions between PETAzo and ZnS-A prevent drug leakage during their in vivo circulation, which not only enhances tumor accumulation but also maintains stability. These nanocapsules with tunable permeability show prolonged retention, remotely controlled drug release, enhanced targeted accumulation, and effective antitumor effects, indicating their potential as an anticancer drug delivery system.
受刺激响应的纳米递药系统的靶向和持续药物释放受到当前使用的纳米结构的不可逆和不可控破坏的限制。通过碱基配对,将胸腺嘧啶修饰的 ZnS(ZnS-A)纳米颗粒(NPs)与光致变色聚偶氮苯(PETAzo)交联,设计仿生纳米胶囊。ZnS-A NPs 将 X 射线转化为使偶氮苯基团异构化的紫外线,这允许活性有效负载跨双层膜扩散。此外,PETAzo 和 ZnS-A 之间的碱基配对相互作用防止了它们在体内循环过程中的药物泄漏,这不仅增强了肿瘤的积累,而且还保持了稳定性。这些具有可调节通透性的纳米胶囊具有延长的保留时间、远程控制的药物释放、增强的靶向积累和有效的抗肿瘤作用,表明它们有作为抗癌药物递送系统的潜力。